Avelumab in Combination With Lorlatinib or Crizotinib in Patients With Previously Treated Advanced NSCLC: Phase 1b/2 Results From the JAVELIN Lung 101 Trial

202412 citationsJournal Articlegold Open Access

Authors

NCT02584634.

Good health and well-being

Published in: JTO Clinical and Research Reports

Volume 5, Issue 7, pp. 100685-100685

Field-Weighted Citation Impact: 1.28